Skip to content


FDA Meeting Update

July 25, 2018

IDT Australia Limited (IDT) provides the following market update regarding the meeting held with the U.S. Food and Drug Administration (FDA) in Washington on 24 July 2018. Ms Michelle Coffey and Dr David Sparling, along with IDT’s U.S. based specialist consultants today attended a meeting with representatives from the FDA’s Office of Manufacturing Quality. The…

Read More »